A drug repurposing approach for individualized cancer therapy based on transcriptome sequencing and virtual drug screening
Onat KadiogluFaranak BahramimehrMona DawoodNuha MahmoudMohamed ElbadawiXiaohua LuY. Emre BulbulJana Agnieszka SchulzLisa KrämerMarie-Kathrin UrschelZoe KünzliLeila AbdulrahmanFadwa AboumaacharLajien KadaloLe Van NguyenSara ShaidaeiNawal ThaherKathrin WalterKarolin Christiane BeslerAndreas SpullerMarkus MunderHenry Johannes GretenThomas Efferth
1
Citation
50
Reference
10
Related Paper
Citation Trend
Keywords:
Drug repositioning
Cite
Citations (81)
Dravet syndrome
Loss function
Cite
Citations (7)
Abstract Given increasing numbers of patients who are undergoing exome or genome sequencing, it is critical to establish tools and methods to interpret the impact of genetic variation. While the ability to predict deleteriousness for any given variant is limited, missense variants remain a particularly challenging class of variation to interpret, since they can have drastically different effects depending on both the precise location and specific amino acid substitution of the variant. In order to better evaluate missense variation, we leveraged the exome sequencing data of 60,706 individuals from the Exome Aggregation Consortium (ExAC) dataset to identify sub-genic regions that are depleted of missense variation. We further used this depletion as part of a novel missense deleteriousness metric named MPC. We applied MPC to de novo missense variants and identified a category of de novo missense variants with the same impact on neurodevelopmental disorders as truncating mutations in intolerant genes, supporting the value of incorporating regional missense constraint in variant interpretation.
Exome
Cite
Citations (353)
Factor IX
Cite
Citations (18)
The GJB2 gene is the most common gene responsible for hearing loss (HL) worldwide, and missense variants are the most abundant type. GJB2 pathogenic missense variants cause nonsyndromic HL (autosomal recessive and dominant) and syndromic HL combined with skin diseases. However, the mechanism by which these different missense variants cause the different phenotypes is unknown. Over 2/3 of the GJB2 missense variants have yet to be functionally studied and are currently classified as variants of uncertain significance (VUS). Based on these functionally determined missense variants, we reviewed the clinical phenotypes and investigated the molecular mechanisms that affected hemichannel and gap junction functions, including connexin biosynthesis, trafficking, oligomerization into connexons, permeability, and interactions between other coexpressed connexins. We predict that all possible GJB2 missense variants will be described in the future by deep mutational scanning technology and optimizing computational models. Therefore, the mechanisms by which different missense variants cause different phenotypes will be fully elucidated.
Cite
Citations (8)
Drug repositioning
Identification
Cancer drugs
Anticancer drug
High-Throughput Screening
Repurposing
Cite
Citations (3)
Amino acid substitution
Cite
Citations (14)
Drug repositioning
Repurposing
Cheminformatics
Chemical database
Cite
Citations (0)
Objective: CENPH, centromere protein H, is one of the constitutive kinetochore proteins. High expression of CENPH has been shown in various forms of cancers; however, studies searching the effect of CENPH mutations in cancers are limited. Therefore, the aim of this study is to investigate the potential effects of the missense mutations of CENPH that have been identified in different cancers.
Materials and Methods: Missense CENPH mutations, which have been observed in cancers, were downloaded from the COSMIC v89. The effect of missense mutations was predicted by using PredictSNP1.0. The protein structure of the CENPH protein was generated with I-TASSER and missense mutations were visualized on CENPH protein with UCSF Chimera. Structural effects of selected mutations were assessed with HOPE.
Results: 34 missense mutations were observed in human cancers. Of the 34 missense mutations 18 mutations were predicted as deleterious and 16 mutations were predicted as neutral with ranging expected accuracies. Predicted missense mutations showed a scattered pattern on 3D CENPH protein. Two of the predicted deleterious missense mutations with higher expected accuracy were further analyzed and assessed according to amino acid properties.
Conclusion: This study provided a systematic analysis and evaluation of missense mutations on a CENPH protein that have been observed in different cancers.
Cite
Citations (0)